Related Experiment Video
Updated: Feb 15, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
Chronic Active Epstein-Barr Virus Disease
Hiroshi Kimura1, Jeffrey I Cohen2
1Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Insights
Chronic active Epstein-Barr virus (CAEBV) disease is a rare, progressive disorder characterized by uncontrolled EBV infection, leading to immunodeficiency and severe complications. Hematopoietic stem cell transplantation is the only effective treatment, while research explores underlying immune defects and genetic causes.
Area of Science:
- Immunology
- Virology
- Hematology
Background:
- Chronic active Epstein-Barr virus (CAEBV) disease is a rare and severe disorder.
- It involves uncontrolled Epstein-Barr virus (EBV) infection, leading to high EBV DNA levels and organ infiltration by EBV-positive lymphocytes.
- Clinical manifestations include fever, lymphadenopathy, splenomegaly, EBV hepatitis, and pancytopenia.
Purpose of the Study:
- To summarize the characteristics, clinical presentation, and treatment of Chronic active Epstein-Barr virus (CAEBV) disease.
- To highlight the progressive nature of the disease, including immunodeficiency and potential fatal outcomes like opportunistic infections, hemophagocytosis, multiorgan failure, and EBV-positive lymphomas.
- To differentiate disease presentation in the US versus Asia and emphasize current research directions.
Main Methods:
- This is a summary and review of existing knowledge on CAEBV.
- Information is synthesized from clinical observations and research findings.
- Focus is on disease characteristics, patient presentation, and treatment efficacy.
Main Results:
- CAEBV is a progressive disease with elevated EBV DNA and lymphocyte infiltration.
- Patients face risks of severe complications including opportunistic infections, hemophagocytosis, multiorgan failure, and lymphomas.
- Disease presentation varies geographically, with US cases often involving B or T cells, and Asian cases involving T or NK cells.
Conclusions:
- Hematopoietic stem cell transplantation is the only proven effective treatment for CAEBV.
- Ongoing research aims to identify the causes of CAEBV, focusing on immune defects and genetic abnormalities.
- Early diagnosis and effective treatment are crucial for managing this rare and life-threatening disorder.
Abstract:
Chronic active Epstein-Barr virus (CAEBV) disease is a rare disorder in which persons are unable to control infection with the virus. The disease is progressive with markedly elevated levels of EBV DNA in the blood and infiltration of organs by EBV-positive lymphocytes. Patients often present with fever, lymphadenopathy, splenomegaly, EBV hepatitis, or pancytopenia. Over time, these patients develop progressive immunodeficiency and if not treated, succumb to opportunistic infections, hemophagocytosis, multiorgan failure, or EBV-positive lymphomas. Patients with CAEBV in the United States most often present with disease involving B or T cells, while in Asia, the disease usually involves T or NK cells. The only proven effective treatment for the disease is hematopoietic stem cell transplantation. Current studies to find a cause of this disease focus on immune defects and genetic abnormalities associated with the disease.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease II: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

